CAMILLE SHAKO: Open Payments
NPI 1477149250 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 26 payments from 12 companies in 2025. Trend: 2023 $46 · 2024 $224 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $135 |
| Lilly USA, LLC | 8 | $134 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $99 |
| Soleno Therapeutics, Inc. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Ascendis Pharma Endocrinology Inc | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Insulet Corporation | 1 | $23 |
| Radius Health, Inc. | 1 | $20 |
| Almatica Pharma LLC | 1 | $19 |
Products named: MOUNJARO, JARDIANCE, Ozempic, Wegovy, VYKAT XR, Kerendia, Yorvipath, CRENESSITY.
Industry payments across NY — which companies pay providers there.
